Human medicinehttps://www.ema.europa.eu/en/homepageHuman medicineen-gbCopyright: (C) European Medicines AgencyWed, 17 Jul 2024 06:50:30 +0200Mon, 22 Apr 2024 14:18:00 +0200Human medicines European public assessment report (EPAR): Jentadueto, linagliptin,metformin hydrochloride, Date of authorisation: 19/07/2012, Revision: 22, Status: Authorisedhttps://www.ema.europa.eu/en/medicines/human/EPAR/jentaduetoHuman medicines European public assessment report (EPAR): Jentadueto, linagliptin,metformin hydrochloride, Date of authorisation: 19/07/2012, Revision: 22, Status: Authorisedhttps://www.ema.europa.eu/en/medicines/human/EPAR/jentaduetoMon, 22 Apr 2024 14:18:00 +0200Human medicineJentadueto : EPAR - Procedural steps taken and scientific information after authorisationhttps://www.ema.europa.eu/system/files/documents/procedural-steps-after/h-2279-steps-after_en.pdfJentadueto : EPAR - Procedural steps taken and scientific information after authorisationhttps://www.ema.europa.eu/system/files/documents/procedural-steps-after/h-2279-steps-after_en.pdfMon, 22 Apr 2024 02:00:00 +0200Human medicine